MENU
SLP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Simulations Plus (SLP) DIvidends Date & History

Simulations Plus Inc is engaged in the software industry... Show more

A.I.Advisor
published Dividends

SLP paid dividends on August 05, 2024

Simulations Plus SLP Stock Dividends
А dividend of $0.06 per share was paid with a record date of August 05, 2024, and an ex-dividend date of July 29, 2024. Read more...

Simulations Plus (SLP) Dividend Analysis: No Current Payout

Key Takeaways

  • Simulations Plus (SLP) does not currently pay a dividend as of mid-2026.
  • The company last paid a quarterly dividend of $0.06 per share in 2024.
  • TTM dividend payout has dropped to $0.00, resulting in a current yield of 0%.
  • Dividend payments were consistent on a quarterly schedule from 2021 through mid-2024 before ceasing.
  • Without an active dividend, the stock does not qualify as a traditional dividend growth or high-yield investment at this time.
  • Financial stability metrics focus on revenue growth and software operations rather than dividend coverage.

Dividend Overview

Simulations Plus, Inc. (SLP) is a developer of modeling and simulation software for the pharmaceutical and biotechnology industries. The company does not currently pay a dividend. Historical records show quarterly payments of $0.06 per share through 2024, with the final ex-dividend date on July 29, 2024, and payment on August 5, 2024. Forward dividend and yield data on major platforms now display as unavailable or zero. SLP is not positioned as a dividend growth stock or high-yield stock; its profile centers on growth through software solutions rather than income distributions.

Dividend History and Growth

SLP maintained a consistent quarterly dividend of $0.06 per share from early 2021 through July 2024, representing a stable but modest payout level without notable increases. No dividend cuts occurred during this period, and payments followed a regular quarterly schedule. However, no dividends have been declared or paid since the August 2024 distribution, leading to a TTM payout of $0.00. The company has not established a long-term dividend growth streak, and its strategy appears to have shifted away from shareholder distributions in recent years.

Dividend Sustainability and Payout Ratio

With no active dividend, traditional sustainability metrics such as payout ratio, earnings coverage, and free cash flow coverage are not applicable. Prior to cessation, the $0.24 annual dividend represented a small portion of earnings, but current financial results show negative EPS in recent periods alongside ongoing operations. Debt levels and cash reserves support business activities, yet the absence of dividends indicates management prioritizes reinvestment or other uses of capital over distributions.

Dividend Compared to Industry Peers

Within the healthcare information services and software sector, many peers maintain modest dividend yields averaging around 1.0% to 1.7%. SLP’s current 0% yield stands below this range, reflecting its decision to suspend payouts. Companies in similar niches often balance software development investments with limited shareholder returns, making SLP’s profile more growth-oriented than income-focused compared to dividend-paying competitors.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening.

Is This Stock Attractive for Dividend Investors?

Simulations Plus (SLP) currently holds limited appeal for income-focused dividend investors due to the absence of payouts. Dividend growth investors seeking consistent increases or reliable quarterly income would find better opportunities elsewhere. Long-term investors prioritizing capital appreciation from software innovation in pharmaceuticals may still consider the stock, while conservative income seekers should look to peers with active dividends. The company’s financial position supports operations but does not extend to distributions at present, making it unsuitable for those relying on dividend income.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
SLP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of software for use in pharmaceutical research

Industry ServicestotheHealthIndustry

Profile
Details
Industry
Packaged Software
Address
800 Park Offices Drive
Phone
+1 661 723-7723
Employees
213
Web
https://www.simulations-plus.com